These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 8530605

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B, Julius JR, Blethen SL.
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [Abstract] [Full Text] [Related]

  • 25. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
    [Abstract] [Full Text] [Related]

  • 29. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 30. Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children.
    de Waal WJ, Greyn-Fokker MH, Stijnen T, van Gurp EA, Toolens AM, de Munick Keizer-Schrama SM, Aarsen RS, Drop SL.
    J Clin Endocrinol Metab; 1996 Mar 18; 81(3):1206-16. PubMed ID: 8772601
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan 18; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 33. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential.
    Toumba M, Kokotsis V, Savva SC, Skordis N.
    J Pediatr Endocrinol Metab; 2014 Mar 18; 27(3-4):311-6. PubMed ID: 24158419
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study.
    Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, Bougnères PF.
    J Clin Endocrinol Metab; 1999 Oct 18; 84(10):3575-8. PubMed ID: 10522998
    [Abstract] [Full Text] [Related]

  • 37. Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency.
    Saggese G, Cesaretti G, Andreani G, Carlotti C.
    Acta Endocrinol (Copenh); 1992 Oct 18; 127(4):307-12. PubMed ID: 1449042
    [Abstract] [Full Text] [Related]

  • 38. Human growth hormone and gonadotropin releasing hormone analog combination therapy increases predicted height in short normal girls.
    Maniati-Christidi M, Livadas S, Voutetakis A, Tolis G, Dacou-Voutetakis C.
    Clin Pediatr (Phila); 2003 Oct 18; 42(1):59-65. PubMed ID: 12635983
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
    Scalco RC, Melo SS, Pugliese-Pires PN, Funari MF, Nishi MY, Arnhold IJ, Mendonca BB, Jorge AA.
    J Clin Endocrinol Metab; 2010 Jan 18; 95(1):328-32. PubMed ID: 19926713
    [Abstract] [Full Text] [Related]

  • 40. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone.
    Chen YD, Shu SG, Chi CS.
    Acta Paediatr Taiwan; 2001 Jan 18; 42(5):291-6. PubMed ID: 11729706
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.